금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
162.30: Japanese Yen falls back to near 40-year lows as intervention risks loom
The Japanese Yen (JPY) has resumed its broader downtrend against the US Dollar (USD) on Monday follo...
WTI Oil falls as oversupply concerns outweigh recent rebound
West Texas Intermediate (WTI) US Oil trades around $68.30 at the time of writing on Monday, down 0.6...
Wall Street Futures Rise Ahead of ISM Services Data as OPEC+ Boosts Oil Output: Dow Jones, S&P, Nasdaq
Futures Advance After Holiday WeekendU. S....
Opinion: Pfizer Is a Fantastic Dividend Stock for Income Investors to Buy Right Now
Pfizer is deeply out of favor on Wall Street, which could be a huge opportunity for long-term dividend investors.
Nancy Pelosi places big bets on two surging tech stocks
Few congressional portfolios attract as much scrutiny as Nancy Pelosi's. Her husband, Paul Pelosi, who executes the family's trades, has previously disclosed bets on Microsoft and Alphabet that outpac ...
The Market Just Pulled Back Again. These 3 Blue Chips Are the Ones to Buy.
Take advantage of short-term weakness by stepping into the right long-term investments when they go on sale.
Dow Jones goes in hard on Verizon
Verizon joined the Dow Jones Industrial Average in 2004, when AT&T was removed and the index needed a new telecommunications name. It held that seat for 22 years. S&P Dow Jones Indices revealed on Jun ...
Apple lobbying to buy memory chips from blacklisted Chinese firm: FT
Trending stocks this week as tech meltdown rattles investors
Is PayPal Stock Cheap, or a Value Trap?
Although the fintech stock trades at a price-to-earnings ratio of 7.8, there is ongoing debate about its investment merits.
This Vanguard Index Fund Could Be the Best Financial Decision You Ever Make
Setting yourself up for a lifetime of wealth doesn't need to be complicated. Buy this ETF and you'll be well on your way!
Prime Day power: Summer sales events challenge Cyber Monday and Black Friday
Anthropic soon to win U.S. clearance to restore Fable 5: Axios
Your health insurer shouldn’t decide your treatment plan. That’s what your doctor — and possibly AI — should be doing.
With a digital health record, clinicians and AI-driven diagnostic tools would be able to see your full health history — and then make better decisions.
BioLife is said to have drawn takeover interest from Repligen